Evaxion announces business update and first quarter 2025 financial results

Copenhagen, denmark, may 27, 2025 - evaxion a/s (nasdaq: evax) (“evaxion”), a clinical-stage techbio company specializing in developing ai-immunology™ powered vaccines, provides business update and announces first quarter 2025 financial results.

EVAX Ratings Summary

EVAX Quant Ranking